Skip to main
Kisspeptin Chemical A research digest on Kisspeptin — the KISS1-gene neuropeptide that sits at the very top of the reproductive axis, read from the published literature, discovery first.

Cancer work uncovered a hormone role

What Is Kisspeptin? A Protein That Starts Hormone Release

You'll see what your brain does with Kisspeptin, why the forms last for different times in your blood, and what no study has proved.

What Kisspeptin is and what your brain does with it

Work on a skin cancer led researchers to Kisspeptin. Their question was why melanoma cells travel through the body. They found the protein's gene during that search. Other teams later traced the protein to your brain.

Kisspeptin fits a receiving spot on certain brain cells. Think of a key fitting one lock. The fit starts hormone release for puberty and sex hormones. Kisspeptin doesn't supply the hormones that come later.

Your body makes more than one form. Studies mainly use kisspeptin-54 and kisspeptin-10. The longer one is called Kisspeptin-54. Researchers call the short form Kisspeptin-10.

The longer form remains in your blood longer. The short form leaves much faster. Both start the same body process. Kisspeptin isn't a food supplement, and no agency has approved it for your care.

What is Kisspeptin doing before puberty begins?

A gene holds your body's directions for making Kisspeptin [1]. The protein then turns on certain brain cells. A hormone leaves those cells and tells the small gland under your brain to act. Sex hormones rise farther down that chain.

Kisspeptin must fit a receiving spot on the brain cell. In 2003, a study involved people who had lacked a working spot since birth. Puberty didn't begin for them [1]. The finding showed why Kisspeptin matters, though Kisspeptin itself isn't a sex hormone.

What is Kisspeptin doing before puberty begins?

Why Kisspeptin-10 is used for brief tests

Kisspeptin-10 is the shortest form used in studies. Its chain has 10 amino acids, the small parts that build a protein. After roughly 4 minutes, half of this form remains in a person's blood. That short stay suits brief blood-test work.

Researchers gave healthy men 1 microgram, or one-millionth of a gram, for each kilogram the man weighed through a vein. Luteinizing hormone rose in their blood [3]. The kisspeptin-10 study didn't find an amount known to be safe for you. It only recorded what happened in that watched group.

Why Kisspeptin-54 lasts longer in blood

Kisspeptin-54 is the longer form in your blood. Its chain contains 54 small protein pieces. Early cancer researchers called this form metastin [8]. The newer name appears in most hormone studies.

A paper gives its weight as about 5857 daltons, a lab unit for weighing particles too small to see. That figure helps a lab tell one form from another. It says nothing about how the protein would feel in your body. The weight doesn't show how well the form works.

The longer chain is harder for blood to break apart. Kisspeptin-54 lasts about 27-28 minutes in people. If you read fertility studies or longer vein tests, you'll often see this form [5]. Kisspeptin-10 fits the same receiving spot, but your blood clears it much faster.

Why a Kisspeptin supplement claim doesn't make it approved care

"Kisspeptin supplement" is a common search, so it is worth saying plainly: kisspeptin is not a dietary supplement. It is an investigational research peptide with no regulatory approval for any indication, studied in Phase 1/2 trials with pharmaceutical-grade material under medical supervision [7]. Research-labelled kisspeptin remains on sale; a label does not verify its identity, purity, or concentration. Treating it as a supplement misstates both its legal status and what is actually known about it.

That leaves the obvious follow-on question: if it is not a supplement, how does prescription care differ from a research vial? In U.S. prescription care, picking a product never settles whether someone will receive it. The kisspeptin entry on mypromise.com belongs to Promise Peptides' prescription-required catalog; a licensed U.S. clinician decides each person's request. The service is prescribing now, yet some requests end in refusal. Its patients must be in the U.S., and state rules can put a particular treatment out of reach. FDA has not approved the compounded kisspeptin preparation. Kisspeptin-10 remains on FDA's Category 2 list, where FDA cites significant safety risks; a prescription does not remove that status.

What older papers may call Kisspeptin

Researchers named the gene for Hershey, Pennsylvania, where they found it in 1996 [8]. The town is known for chocolate. That history explains the word "kiss" in Kisspeptin. The name began with cancer work, not a claim about your desire.

Early cancer papers call the long form metastin. The newer name is kisspeptin-54. Papers written before 2003 may use the older name. When you read either name, you aren't looking at two different proteins.

Which hormones Kisspeptin starts but doesn't supply

Kisspeptin makes brain cells release gonadotropin-releasing hormone. That hormone tells the pituitary gland (the pea-size gland under your brain) to release two more. One helps release an egg or prompts the testes to produce testosterone. The other helps an egg grow or helps make sperm [1].

Kisspeptin isn't any of those later hormones. It gives the first order, then your own cells do the work. Think of a foreman giving an order without doing each task. The kisspeptin mechanism of action page follows the body process.